Skip NavigationSkip to Content

Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic

  1. Author:
    Savid-Frontera, Constanza [ORCID]
    Viano, Maria E [ORCID]
    Baez, Natalia S [ORCID]
    Reynolds, Della
    Matellon, Mariana
    Young,Howard [ORCID]
    Rodriguez-Galan, Maria C [ORCID]
  2. Author Address

    Inmunolog 237;a, CIBICI-CONICET, Facultad de Ciencias Qu 237;micas, Universidad Nacional de C 243;rdoba, C 243;rdoba, 5000, Argentina., Cancer & Inflammation Program, Center for Cancer Research, National Cancer Institute, Frederick, MD 21702-1201 USA.,
    1. Year: 2021
    2. Date: Nov 16
    3. Epub Date: 2021 Nov 16
  1. Journal: Immunotherapy
  2. Type of Article: Article
  3. ISSN: 1750-743X
  1. Abstract:

    Aim: The aim of this work is to utilize a gene expression procedure to safely express systemic IL-12 and evaluate its effects in mouse tumor models. Materials & methods: Secondary lymphoid organs and tumors from EL4 and B16 tumor-bearing mice were analyzed by supervised and unsupervised methods. Results: IL-12 cDNA induced systemic IL-12 protein levels lower than the tolerated dose in patients. Control of tumor growth was observed in subcutaneous B16 and EL4 tumors. Systemic IL-12 expression induced a higher frequency of both total tumor-infiltrated CD45+ cells and proliferative IFN-?+CD8+ 160;T cells along with a lower frequency of CD4+FOXP3+ and CD11b+Gr-1+ cells. Conclusion: This approach characterizes the systemic effects of IL-12, helping to improve 160;treatment of metastases or solid tumors.

    See More

External Sources

  1. DOI: 10.2217/imt-2021-0080
  2. PMID: 34783257
  3. WOS: 000718900100001

Library Notes

NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel